''anonymity in an unlinkable fashion'' using encryption with a hash function. Finally, the registry resumed registering cases of esophageal cancer that had been treated in 2001.
In the Comprehensive Registry in 2003, we newly inserted Figure 3 : Survival of patients treated by EMR/ ESD in relation to the pathological depth of tumor invasion (pT); Figure 4 : Survival of patients treated by EMR/ESD in relation to the lymphatic or blood vessel invasion, in order to present the treatment outcome depending on the pathological status.
We briefly summarized the Comprehensive Registry of Esophageal Cancer in Japan, 2003. A total of 4659 cases were registered from 199 institutions in Japan. Comparing the Comprehensive Registry in 2003 to the Comprehensive Registry in 2002, the number of registered cases and surgical cases increased by 378 and 509, respectively, although the number of registered institutions decreased by 23. As for the histologic type of cancer according to biopsy specimens, squamous cell carcinoma and adenocarcinoma accounted for 92.2% and 3.0%, respectively. Regarding clinical results, the 5-year survival rates of patients treated using endoscopic mucosal resection, concurrent chemoradiotherapy, radiotherapy alone, chemotherapy alone, or esophagectomy were 80.0%, 21.9%, 30.3%, 3.0%, and 46.6%, respectively. Concerning the approach used to perform an esophagectomy, 15.5% of the cases were performed endoscopically, that is, thoracoscopically, laparoscopically, or mediastinoscopically. Regarding the reconstruction route, the posterior mediastinal, the retrosternal, and the intrathoracic route were used in 37.3%, 33.3% and 15.7% of cases, respectively. The operative mortality was 1.0% (25 out of 2510 cases).
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